- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/06 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies from serum
Patent holdings for IPC class C07K 16/06
Total number of patents in this class: 1104
10-year publication summary
|
73
|
88
|
131
|
107
|
89
|
108
|
84
|
62
|
55
|
21
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2712 |
42 |
| Regeneron Pharmaceuticals, Inc. | 4701 |
40 |
| Genentech, Inc. | 4104 |
35 |
| Amgen Inc. | 4427 |
35 |
| Cytiva BioProcess R&D AB | 322 |
34 |
| CSL Behring AG | 185 |
31 |
| Hoffmann-La Roche Inc. | 3793 |
30 |
| F. Hoffmann-La Roche AG | 7837 |
29 |
| Biotest AG | 103 |
18 |
| Bristol-myers Squibb Company | 4742 |
13 |
| Plasma Technologies, LLC | 25 |
12 |
| ADMA Biomanufacturing, LLC | 31 |
12 |
| AbbVie Biotechnology Ltd. | 178 |
11 |
| Janssen Biotech, Inc. | 1764 |
11 |
| EMD Millipore Corporation | 631 |
10 |
| Bio-Rad Laboratories, Inc. | 1610 |
10 |
| Momenta Pharmaceuticals, Inc. | 291 |
10 |
| The Rockefeller University | 584 |
10 |
| The Johns Hopkins University | 5882 |
9 |
| Grifols Worldwide Operations Limited | 290 |
9 |
| Other owners | 693 |